School of Medicine
Showing 91-100 of 107 Results
-
Wenjun Wang
Postdoctoral Scholar, Stem Cell Transplantation
Current Research and Scholarly InterestsMy postdoctoral research focuses on investigating novel therapy for childhood leukemias.
-
Yidan Wang
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioI joined Dr. John Benjamin’s lab to study the heterogeneity of neutrophils across developmental stages and during bronchopulmonary dysplasia (BPD). My research focuses on characterizing neutrophil subsets and investigating the contributions of distinct neutrophil subsets to the development of BPD.
My predoctoral training was completed at Northwestern University under the co-mentorship of Dr. Harris Perlman and Dr. Deborah Winter. I studied the heterogeneity and functions of monocyte-lineage cells and macrophages in mouse synovial tissue under both steady-state and inflammatory arthritis conditions. -
Mulate Zerihun Workeneh
Postdoctoral Scholar, Critical Care
BioDr. Mulate Zerihun Workeneh is a Postdoctoral Scholar in Dr. Bereketeab Haileselassie’s laboratory in the Department of Pediatrics at Stanford University School of Medicine. He earned a Ph.D. in Medical Sciences from the Azrieli Faculty of Medicine at Bar-Ilan University, Israel, where he developed peptide therapeutics that target mitochondrial protein-protein interactions involved in cardiovascular disease. Dr. Workeneh’s research uses medicinal chemistry, chemical biology, peptide engineering, computational modeling and mitochondrial biology to understand how the disease occurs and to develop new ways to treat it. During his doctoral training, he designed and evaluated novel linear and macrocyclic peptide inhibitors that alter mitochondrial dynamics to mitigate mitochondrial dysfunction and cardiovascular injury. His work at Stanford is focused on defining the role of mitochondrial dynamics in endothelial dysfunction in sepsis and multiple organ dysfunction syndrome (MODS). He is working to develop peptide-based therapeutics that maintain mitochondrial function, improve vascular health and prevent organ failure in critically ill patients by integrating approaches in chemical biology, molecular and cellular biology, and translational drug discovery. Dr. Workeneh has publications in leading medicinal chemistry, pharmacology, and mitochondrial biology journals and is an inventor on patents related to mitochondrial protein-protein interaction inhibitors. His goal is to translate advances in mitochondrial biology into first-in-class therapeutics for cardiovascular disease, sepsis, and other disorders linked to mitochondrial dysfunction. He is excited to work across disciplines at Stanford to help push biomedical research forward.
-
Chongyang Zhang
Postdoctoral Scholar, Cardiology
BioDr. Zhang is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. She has a PhD in Pharmacology from University of Rochester, NY. She has research in cardiovascular research and chronobiology published in high impact peer-reviewed journals. She is recipient of honors including predoctoral fellowship from AHA, Travel Grant for Early Career Investigators from Council on Arteriosclerosis, Thrombosis, and Vascular Biology. She has served as ad hoc reviewer for more than 40 manuscripts for reputed journals.
-
Lu Zhang
Postdoctoral Scholar, Endocrinology and Metabolism
BioLu is a postdoctoral research scholar in Dr. Anna Gloyn's Translational Genomics of Diabetes Lab. During her master's and doctoral studies, she focused on epigenomics and single-cell multi-omics analysis, with an emphasis on 3D genomics. Her research included developing Hi-Tag, a chromatin conformation capture technique designed for use with small cell samples. This method provides valuable insights into the organization of chromatin in the cell. She has built strong expertise in combining different types of biological data, including RNA-seq, ATAC-seq, chromatin interaction data, and single-cell data. She has contributed to several research projects as a co-author, including studies that used genome-wide association studies (GWAS) and GTEX data to connect multi-omics data with functional genomics. These experiences have helped her gain a deep understanding of how to integrate different types of genomic data to solve complex biological problems. Currently, Lu is focused on applying her research skills to diabetes.
